Here, we report the presence of an inverse association of plasma NfL levels, acquired from cases with either prodromal (β-amyloid-positive MCI) or early clinical β-amyloid-positive AD, with their levels of cortical microglial activation measured with 11C-(R)-PK11195 PET [17]. The gene discussed is NEFL; the disease is Alzheimer disease.